Top compounds associated with response to SLC7A2


Feature Type Standardized
Nominal ANOVA
mRNA QS11 GDSC1000 pan-cancer AAC 0.11 0.004
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.004
mRNA neratinib CTRPv2 pan-cancer AAC -0.1 0.004
mRNA silmitasertib CTRPv2 pan-cancer AAC -0.11 0.004
mRNA AR-42 GDSC1000 pan-cancer AAC 0.088 0.005
mRNA SMER-3 CTRPv2 pan-cancer AAC -0.11 0.005
mRNA BMS-754807 GDSC1000 pan-cancer AAC 0.095 0.006
mRNA CEP-701 GDSC1000 pan-cancer AAC 0.093 0.007
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.093 0.007
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.008
Download CSV